The Fetal Medicine Foundation

Home
Courses & Congress
FMF Certification
FMF fellowships
- FMF fellowships
- Diploma in fetal medicine
Education
Calculators
Prediction of risk
Preeclampsia
11⁺⁰ to 14⁺¹ weeks
19⁺⁰ to 24⁺⁶ weeks
30⁺⁰ to 37⁺⁶ weeks
Small for Gestational Age
Trisomies
Gestational diabetes
Miscarriage
Stillbirth
Fetal macrosomia
Preterm birth - history
Preterm birth - cervix
Assessment / management
Management: SGA
Management: Fetal anemia
Pregnancy dating
Assessment: Fetal growth
Assessment: Birth weight
Assessment: Fetal Doppler
Assessment: Uterine PI
Assessment: Nuchal translucency
Performance audits
Mean arterial pressure
Uterine artery PI
Nuchal translucency
Ductus venosus PIV
Serum sFLT-1
Serum PLGF
Serum PAPP-A
Serum free β-hCG
Research tools
Batch MoMs calculation
Batch preeclampsia risks
Research
Look for Life
- Support in developing countries
- Support in developed countries
  - Southend hospital, UK
  - Attikon hospital, Greece
Contact us

Showing publications 1 - 1 of 1 (Page 1 of 1)

Nuchal translucency and the risk of congenital heart disease.
Hyett J, Sonek J, Nicolaides KH.
Obstet Gynecol 2007;109:1455-6.

5269

Publication filters

Year

Search

22^nd World Congress in Fetal Medicine

29^th June - 3^rd July, Prague, Czechia
For more information click here
Online registration is closed

FMF own page

If you want to visit your own FMF page please click here.

© 2025 The Fetal Medicine Foundation

Please wait...

Modal title